Uniphar PLC Hits 52-Week High Amid Strategic GCC Expansion and Mixed Analyst Sentiment
Uniphar PLC has reached a new 52-week high, trading at GBX 348, and is expanding its reach through a strategic agreement with Santhera Pharmaceuticals to distribute a treatment for Duchenne muscular dystrophy in the GCC region.
2 minutes to read